连云港首台“肿瘤狙击手”射波刀开机启用

Core Viewpoint - The successful launch of the "CyberKnife" at Lianyungang First People's Hospital marks a significant advancement in high-precision and intelligent radiotherapy for cancer treatment, aligning with China's health strategy and enhancing regional oncology capabilities [2][3]. Group 1: Event Overview - The second academic conference of the Jiangsu Immunology Society's Nutrition and Immunity Committee was held in Lianyungang on December 20, featuring the inauguration of the "CyberKnife" radiotherapy system [2]. - Experts from various medical institutions attended the conference, including leaders from the Beijing-Japan Friendship Hospital and Jiangsu Provincial Cancer Hospital, who participated in the unveiling ceremony of the "CyberKnife" [2]. Group 2: Technology and Benefits - The "CyberKnife" is a high-precision radiotherapy system that miniaturizes a linear accelerator and mounts it on a robotic arm, offering advantages such as omnidirectional focusing, multi-angle incidence, and real-time dynamic tracking of tumor targets [3]. - The system is designed to provide non-invasive, precise, efficient, and safe treatment options for patients with tumors in multiple body parts, especially for those who cannot tolerate surgery or have poor outcomes with traditional radiotherapy [3]. Group 3: Strategic Implications - The launch of the "CyberKnife" is part of the hospital's efforts to respond to the "Healthy China" strategy and aims to enhance the development of oncology disciplines, clinical research, and technological innovation [3]. - A professional team will be established to maximize the effectiveness of the "CyberKnife," aiming to benefit more cancer patients [3].